Faculty who have authored publication Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART).
| Name | Title | Department | Institution |
|---|---|---|---|
| Razelle Kurzrock MD | Center Associate Director, Professor | Medicine | Medical College of Wisconsin |
